Cargando…
Liquid Biopsy in Neurological Diseases
The most recent and non-invasive approach for studying early-stage biomarkers is liquid biopsy. This implies the extraction and analysis of non-solid biological tissues (serum, plasma, saliva, urine, and cerebrospinal fluid) without undergoing invasive procedures to determine disease prognosis. Liqu...
Autores principales: | Malhotra, Sunny, Miras, Mari Carmen Martín, Pappolla, Agustín, Montalban, Xavier, Comabella, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378132/ https://www.ncbi.nlm.nih.gov/pubmed/37508574 http://dx.doi.org/10.3390/cells12141911 |
Ejemplares similares
-
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure
por: Malhotra, Sunny, et al.
Publicado: (2023) -
Chitinases and chitinase-like proteins as biomarkers in neurologic
disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020) -
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022) -
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015) -
Cell-free DNA-based liquid biopsies in neurology
por: Gaitsch, Hallie, et al.
Publicado: (2022)